Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

ESMO 2012 /
Treating liver metastases in colorectal cancer

28th Sep - 2nd Oct 2012

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 04.10.12
Views: 4511

Dr Gunnar Folprecht - University Cancer Center, Dresden, Germany

Dr Gunnar Folprecht talks with ecancer at the 2012 ESMO meeting about treating liver metastases in colorectal cancer.


In recent years, oncologists learned that patients who are non-resective could become resective after chemotherapy, thus allowing for increased long-term survival and even cure by removing metastases through surgery.


The challenges now are finding the optimal treatment for shrinking of liver metastasis and learning which patients will benefit the most from this. In addition, there is a need for multidisciplinary cooperation to implement more surgery in patients with liver metastasis.


Filming supported by Amgen

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation